TipRanks
Cormedix (CRMD)
NASDAQ:CRMD
US Market
Want to see CRMD full AI Analyst Report?

Cormedix (CRMD) Ratios

1,735 Followers

Cormedix Ratios

CRMD's free cash flow for Q2 2026 was $0.76. For the 2026 fiscal year, CRMD's free cash flow was decreased by $ and operating cash flow was $0.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.56 2.11 3.39 6.97 9.44
Quick Ratio
2.36 1.94 3.16 6.78 9.44
Cash Ratio
1.37 0.84 1.20 3.83 6.87
Solvency Ratio
0.50 0.42 -0.52 -3.88 -4.23
Operating Cash Flow Ratio
1.36 1.00 -1.50 -3.37 -3.86
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 37.34M$ -53.78M$ 80.39M$ 67.53M$ 52.57M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.18 <0.01 <0.01 0.01
Debt-to-Equity Ratio
0.31 0.37 <0.01 <0.01 0.01
Debt-to-Capital Ratio
0.24 0.27 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.24 0.26 0.00 0.00 0.00
Financial Leverage Ratio
1.96 2.04 1.40 1.17 1.13
Debt Service Coverage Ratio
84.39 65.00 -483.01 0.00 -1.11K
Interest Coverage Ratio
78.49 53.97 -614.10 0.00 -1.15K
Debt to Market Cap
0.24 0.17 0.00 0.00 0.00
Interest Debt Per Share
1.89 2.11 <0.01 0.01 0.02
Net Debt to EBITDA
-0.45 0.02 2.11 0.93 1.42
Profitability Margins
Gross Profit Margin
82.78%88.46%92.66%0.00%94.29%
EBIT Margin
46.41%49.02%-44.37%0.00%-46264.69%
EBITDA Margin
53.99%53.83%-43.66%0.00%-45945.10%
Operating Profit Margin
46.95%48.17%-51.43%0.00%-46819.91%
Pretax Profit Margin
44.00%48.13%-44.45%0.00%-46305.23%
Net Profit Margin
40.49%52.31%-41.24%0.00%-45409.90%
Continuous Operations Profit Margin
40.49%52.31%-41.24%0.00%-45409.90%
Net Income Per EBT
92.02%108.69%92.78%100.00%98.07%
EBT Per EBIT
93.72%99.92%86.44%94.65%98.90%
Return on Assets (ROA)
20.70%19.74%-15.09%-56.47%-47.88%
Return on Equity (ROE)
44.64%40.23%-21.18%-66.06%-53.94%
Return on Capital Employed (ROCE)
30.29%23.03%-26.30%-69.29%-54.95%
Return on Invested Capital (ROIC)
27.87%22.98%-24.35%-69.14%-53.76%
Return on Tangible Assets
36.30%39.10%-15.32%-56.47%-47.88%
Earnings Yield
30.40%19.46%-3.76%-24.21%-17.54%
Efficiency Ratios
Receivables Turnover
2.87 1.82 0.84 0.00 0.00
Payables Turnover
7.78 4.56 1.85 0.05 <0.01
Inventory Turnover
2.06 1.21 0.42 0.10 0.00
Fixed Asset Turnover
58.87 31.41 18.73 0.00 0.03
Asset Turnover
0.51 0.38 0.37 0.00 <0.01
Working Capital Turnover Ratio
1.69 2.28 0.58 0.00 <0.01
Cash Conversion Cycle
257.32 422.10 1.11K -3.86K -215.26K
Days of Sales Outstanding
127.37 200.51 433.69 0.00 0.00
Days of Inventory Outstanding
176.89 301.61 869.39 3.74K 0.00
Days of Payables Outstanding
46.94 80.02 196.79 7.60K 215.26K
Operating Cycle
304.26 502.12 1.30K 3.74K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
3.24 2.43 -0.86 -0.75 -0.61
Free Cash Flow Per Share
3.21 2.40 -0.86 -0.76 -0.61
CapEx Per Share
0.03 0.03 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99 0.99 1.00 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
114.08 77.45 -437.35 -117.35 -111.04
Capital Expenditure Coverage Ratio
114.08 77.45 -437.35 -117.35 -111.04
Operating Cash Flow Coverage Ratio
1.75 1.18 -97.90 -57.53 -30.35
Operating Cash Flow to Sales Ratio
0.55 0.56 -1.16 0.00 -372.38
Free Cash Flow Yield
40.87%20.62%-10.64%-20.24%-14.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.26 5.17 -26.60 -4.13 -5.70
Price-to-Sales (P/S) Ratio
1.33 2.69 10.97 0.00 2.59K
Price-to-Book (P/B) Ratio
1.34 2.07 5.63 2.73 3.08
Price-to-Free Cash Flow (P/FCF) Ratio
2.45 4.85 -9.40 -4.94 -6.89
Price-to-Operating Cash Flow Ratio
2.42 4.79 -9.42 -4.98 -6.95
Price-to-Earnings Growth (PEG) Ratio
0.02 >-0.01 0.40 -0.18 4.28
Price-to-Fair Value
1.34 2.07 5.63 2.73 3.08
Enterprise Value Multiple
2.02 5.01 -23.01 -3.21 -4.22
Enterprise Value
504.31M 840.84M 436.73M 148.42M 126.81M
EV to EBITDA
2.02 5.01 -23.01 -3.21 -4.22
EV to Sales
1.09 2.70 10.05 0.00 1.94K
EV to Free Cash Flow
2.00 4.87 -8.61 -3.83 -5.16
EV to Operating Cash Flow
1.99 4.80 -8.63 -3.86 -5.21
Tangible Book Value Per Share
0.92 -0.05 1.41 1.38 1.37
Shareholders’ Equity Per Share
5.87 5.63 1.44 1.38 1.37
Tax and Other Ratios
Effective Tax Rate
0.08 -0.09 0.07 0.00 0.02
Revenue Per Share
5.89 4.33 0.74 0.00 <0.01
Net Income Per Share
2.39 2.26 -0.30 -0.91 -0.74
Tax Burden
0.92 1.09 0.93 1.00 0.98
Interest Burden
0.95 0.98 1.00 1.00 1.00
Research & Development to Revenue
0.06 0.06 0.09 0.00 163.28
SG&A to Revenue
0.30 0.10 1.35 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.04 0.14 0.00 62.22
Income Quality
2.07 1.07 2.82 0.83 0.82
Currency in USD